Dr Mazen Hassanain | Founder

Dr Mazen Hassanain, Founder, SaudiVax

Dr. Mazen Hassanain graduated from King Saud University’s college of medicine in Riyadh, Saudi Arabia, in 1999 with a 2nd degree honor. He then joined the academic staff of the Department of General Surgery at King Saud University. Dr. Hassanain then went on to complete 5 years of training in General Surgery at McGill University. He is now a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC), as well as The American College of Surgery. He holds certificates in both Hepato-Pancreato-Biliary Surgery and Surgical Oncology from completing his training at McGill University. In the last 8 years, he has presented 60 orals/posters at 50 national and international meetings, which has resulted in 80 peer-reviewed publications. Dr. Hassanain’s ability to balance a very busy clinical practice with his research activities has allowed him to simultaneously complete a Ph.D. science degree in the Division of Experimental Surgery. Dr. Hassanain is an Associate Professor in the Department of Surgery, College of Medicine, a member of the HPB and Solid Organ Transplant team at King Saud University and adjunct professor at the Department of Oncology at McGill University and at the Department of Pediatrics at Baylor College of Medicine. In 2014, he created and led the Vaccine and Biologics Development and Manufacturing strategic program at King Saud University, which is focused on vaccine R&D. He the founded SaudiVax a private entity focused on vaccine manufacturing for the OIC needs. He also co-established the National Vaccine Development Coalition Team, an alliance between the Saudi government, local academia and industry in the field of vaccine development.


DC Co-conference Day 2 April 4 @ 5:40

Uniting Saudi MERS clusters and controlling the continuing outbreak

back to speakers